Cervical, breast, heart, bowel: here’s what women should be getting screened regularly
Throughout the COVID-19 pandemic, many have felt anxious about going to the GP and other health facilities, believing these places have had a greater...
Severely stressful things worsen long COVID, study finds
Severely stressful things were some of the strongest predictors of whether a patient hospitalized for COVID-19 would experience symptoms of long COVID.
Women may have higher risk for long COVID
In a study from Northeastern and elsewhere, scientists found new information about the prevalence of post-acute sequelae of SARS-CoV-2 infection, otherwise known as "long...
Some bacteria in mouth linked to high blood pressure
High blood pressure is typically defined by two measurements: systolic blood pressure (the upper number measuring pressure when the heart beats) of 130 mm...
Meds for sleep problem may help treat drug and alcohol addiction
Overdose deaths have skyrocketed past 100,000 a year and existing treatment options have limited efficacy.
In a study from Rutgers and elsewhere, scientists found a...
Diabetes drugs may benefit all people with heart failure
There are more than 64 million people worldwide affected by heart failure, half of whom have mildly reduced or preserved ejection fraction.
In a study from Brigham...
Scientists may find the cause of long COVID ‘brain fog’
Long COVID is marked by neurological symptoms such as memory loss, sensory confusion, severe headaches, and even stroke in up to 30 percent of cases,...
Scientists find new way to reduce blood pressure effectively
In a study from the University of Houston, scientists found that deep nerve stimulation consistently reduces blood pressure.
They found that blood pressure and renal...
Highly processed foods may be addictive like tobaccos
In a study from the University of Michigan and Virginia Tech, scientists found that highly processed foods may be addictive like tobacco.
Their analysis took...
Common diabetes drug can slow kidney function decline, study finds
In a study from University Medical Center Groningen, scientists found that dapagliflozin— a sodium-glucose cotransporter 2 inhibitor prescribed to treat diabetes—reduces the rate of...